Argenx
ARGX
#638
Rank
$31.87 B
Marketcap
$533.00
Share price
-0.62%
Change (1 day)
3.69%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : $33.96 M

According to Argenx 's latest financial reports the company's total debt is $33.96 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31$12.42 M8.38%
2021-12-31$11.46 M-2.88%
2020-12-31$11.8 M43.64%
2019-12-31$8.21 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31$2.95 M3.85%
2011-12-31$2.84 M